Profil
Antonin Rollet de Fougerolles is currently Chairman at eTheRNA immunotherapies NV since 2024.
Other current roles include Director at Chimeron Bio Corp., Director at Walking Fish Therapeutics, Inc., Non-Executive Director at ChemAI Ltd. since 2024, and Director at Valerio Therapeutics SA. Former positions include Chief Executive Officer & Director at Evox Therapeutics Ltd. from 2018 to 2024, Chief Scientific Officer at Tolerx, Inc. from 2010 to 2011, VP-Research, Immunology, Metabolic & Viral Disease at Alnylam Pharmaceuticals, Inc. from 2009 to 2010, Chief Scientific Officer at Ablynx NV from 2013 to 2018, and Chief Scientific Officer at ModernaTX, Inc. Education includes a doctorate from Harvard University.
Aktiva positioner av Antonin Rollet de Fougerolles
| Företag | Position | Start |
|---|---|---|
| DEEPMATTER GROUP PLC | Direktör/Styrelseledamot | 2024-11-27 |
| VALERIO THERAPEUTICS | Direktör/Styrelseledamot | - |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Direktör/Styrelseledamot | - |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Direktör/Styrelseledamot | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Operates as a technology platform that develops mRNA and lipid nanoparticle therapeutics | Ordförande | 2024-07-10 |
Tidigare kända positioner av Antonin Rollet de Fougerolles
| Företag | Position | Slut |
|---|---|---|
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Verkställande Direktör | 2024-04-29 |
| ABLYNX | Teknisk/Vetenskaplig/F&U Direktör | 2018-02-01 |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | 2011-12-19 |
| ALNYLAM PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2010-01-01 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░ | - |
Antonin Rollet de Fougerolless utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Valerio Therapeutics SA
Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
DeepMatter Group Plc
DeepMatter Group Plc Packaged SoftwareTechnology Services Develops AI-powered predictive chemistry solutions | Technology Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Operates as a technology platform that develops mRNA and lipid nanoparticle therapeutics | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Health Technology |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Health Technology |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Health Technology |
















